APA
Misof B. M., Roschger P., Gabriel D., Paschalis E. P., Eriksen E. F., Recker R. R., Gasser J. A. & Klaushofer K. (20130829). Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
Chicago
Misof Barbara M, Roschger Paul, Gabriel Daniela, Paschalis Eleftherios P, Eriksen Erik F, Recker Robert R, Gasser Jürg A and Klaushofer Klaus. 20130829. Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
Harvard
Misof B. M., Roschger P., Gabriel D., Paschalis E. P., Eriksen E. F., Recker R. R., Gasser J. A. and Klaushofer K. (20130829). Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
MLA
Misof Barbara M, Roschger Paul, Gabriel Daniela, Paschalis Eleftherios P, Eriksen Erik F, Recker Robert R, Gasser Jürg A and Klaushofer Klaus. Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 20130829.